NASDAQ:HCWB HCW Biologics (HCWB) Stock Price, News & Analysis $4.13 -0.11 (-2.59%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$4.20 +0.08 (+1.82%) As of 08/1/2025 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock About HCW Biologics Stock (NASDAQ:HCWB) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get HCW Biologics alerts:Sign Up Key Stats Today's Range$4.05▼$4.1950-Day Range$3.75▼$8.3752-Week Range$3.55▼$100.80Volume19,934 shsAverage Volume113,650 shsMarket Capitalization$5.95 millionP/E RatioN/ADividend YieldN/APrice Target$35.00Consensus RatingBuy Company Overview HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States. The company's lead products include HCW9218, which is in Phase 1 clinical chemo-refractory/chemo-resistant solid tumors with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as Phase 2 clinical trial with metastatic advanced stage ovarian cancer patients; and HCW9302 for autoimmune and proinflammatory diseases, such as alopecia areata diseases. It also develops HCW9201, a cell-based therapy that is in Phase I clinical trials for the treatment of patients with relapsed/refractory acute myelogenous leukemia; and HCW9206, an injectable immunotherapeutic to use as adjuvant for adoptive cell therapy in cancer treatment. HCW Biologics Inc. was incorporated in 2018 and is headquartered in Miramar, Florida. Read More HCW Biologics Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks54th Percentile Overall ScoreHCWB MarketRank™: HCW Biologics scored higher than 54% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingHCW Biologics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageHCW Biologics has only been the subject of 1 research reports in the past 90 days.Read more about HCW Biologics' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of HCW Biologics is -0.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of HCW Biologics is -0.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about HCW Biologics' valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.84% of the float of HCW Biologics has been sold short.Short Interest Ratio / Days to CoverHCW Biologics has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in HCW Biologics has recently decreased by 65.99%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldHCW Biologics does not currently pay a dividend.Dividend GrowthHCW Biologics does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted2.84% of the float of HCW Biologics has been sold short.Short Interest Ratio / Days to CoverHCW Biologics has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in HCW Biologics has recently decreased by 65.99%, indicating that investor sentiment is improving significantly. News and Social Media0.0 / 5News SentimentN/A Search InterestOnly 1 people have searched for HCWB on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership3.3 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, HCW Biologics insiders have bought more of their company's stock than they have sold. Specifically, they have bought $305,032.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders42.70% of the stock of HCW Biologics is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 2.96% of the stock of HCW Biologics is held by institutions.Read more about HCW Biologics' insider trading history. Receive HCWB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for HCW Biologics and its competitors with MarketBeat's FREE daily newsletter. Email Address HCWB Stock News HeadlinesHCW Biologics Inc News (HCWB) - Investing.comJuly 2, 2025 | investing.comInsiders Re-Evaluate Their US$3.05m Stock Purchase As HCW Biologics Falls To US$6.9mJuly 2, 2025 | uk.finance.yahoo.comCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? Depending on when you watch this new training, crypto income could be hitting your account as early as tonight! | Awesomely, LLC (Ad)HCW Biologics Completes Warrant Exercise with ArmisticeJuly 1, 2025 | tipranks.comHCW Biologics to Showcase Important Updates on IND-Enabling Studies and Preclinical Success of Its Novel Multi-Specific T-Cell Engagers Against Solid TumorsJune 27, 2025 | globenewswire.comHCW Biologics Inc.: HCW Biologics Regains Compliance with Nasdaq Capital Market RequirementsJune 26, 2025 | finanznachrichten.deHCW Biologics Regains Nasdaq Compliance as of June 2025June 26, 2025 | tipranks.comHCW Biologics Regains Compliance with Nasdaq Capital Market RequirementsJune 26, 2025 | globenewswire.comSee More Headlines HCWB Stock Analysis - Frequently Asked Questions How have HCWB shares performed this year? HCW Biologics' stock was trading at $17.8440 on January 1st, 2025. Since then, HCWB shares have decreased by 76.9% and is now trading at $4.13. How were HCW Biologics' earnings last quarter? HCW Biologics Inc. (NASDAQ:HCWB) announced its quarterly earnings results on Thursday, May, 15th. The company reported ($0.05) earnings per share for the quarter. When did HCW Biologics' stock split? HCW Biologics shares reverse split before market open on Friday, April 11th 2025.The 1-40 reverse split was announced on Tuesday, April 1st 2025. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, April 10th 2025. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. When did HCW Biologics IPO? HCW Biologics (HCWB) raised $45 million in an initial public offering (IPO) on Tuesday, July 20th 2021. The company issued 5,600,000 shares at a price of $8.00 per share. EF Hutton served as the underwriter for the IPO and Revere Securities was co-manager. How do I buy shares of HCW Biologics? Shares of HCWB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of HCW Biologics own? Based on aggregate information from My MarketBeat watchlists, some other companies that HCW Biologics investors own include Jiuzi (JZXN), Faraday Future Intelligent Electric (FFIE), AMC Entertainment (AMC), Kiora Pharmaceuticals (KPRX), Rallybio (RLYB), Adial Pharmaceuticals (ADIL) and Aridis Pharmaceuticals (ARDS). Company Calendar Last Earnings5/15/2025Today8/02/2025Next Earnings (Estimated)8/13/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - BIOMED/GENE Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:HCWB CIK1828673 Webwww.hcwbiologics.com Phone954-842-2024Fax954-842-2037Employees40Year FoundedN/APrice Target and Rating Average Price Target for HCW Biologics$35.00 High Price Target$35.00 Low Price Target$35.00 Potential Upside/Downside+747.5%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Trailing Twelve Months)($23.25) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$30.02 million Net Margins-1,712.94% Pretax Margin-1,713.01% Return on EquityN/A Return on Assets-90.09% Debt Debt-to-Equity RatioN/A Current Ratio0.07 Quick Ratio0.07 Sales & Book Value Annual Sales$2.57 million Price / Sales2.31 Cash FlowN/A Price / Cash FlowN/A Book Value($6.08) per share Price / Book-0.68Miscellaneous Outstanding Shares1,440,000Free Float825,000Market Cap$5.95 million OptionableNot Optionable Beta0.66 Social Links (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free Report This page (NASDAQ:HCWB) was last updated on 8/3/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredTurn $1K into $50K with This DeFi GemBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredEx-Hedge Fund Manager Uncovers $100 Trillion Land ShiftTrump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...Stansberry Research | SponsoredInvestigating the Most Controversial Stock on EarthTesla’s wild price swings may not be random after all. Hedge fund veteran Larry Benedict has uncovered a st...Brownstone Research | SponsoredThis New Rule Could Change EverythingA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredSell these "safe" blue chips immediatelyInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HCW Biologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HCW Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.